BFM
LXRX icon

Boothbay Fund Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Boothbay Fund Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.1K Hold
44,315
– – ﹤0.01% 1901
2025
Q4 		$51K Sell
44,315
-11,805
-21% -$16.2K ﹤0.01% 1820
2025
Q3 		$75.8K Hold
56,120
– – ﹤0.01% 1754
2025
Q2 		$53.1K Sell
56,120
-398,771
-88% -$258K ﹤0.01% 1350
2025
Q1 		$210K Sell
454,891
-25,931
-5% -$16.4K 0.01% 1152
2024
Q4 		$355K Buy
+480,822
New +$580K 0.01% 1018
2024
Q1 		– Sell
-14,400
Closed -$22K – 1823
2023
Q4 		$22K Buy
+14,400
New +$17.1K ﹤0.01% 1582

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.26B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return